Mid
N
NVOAI Stock Diagnostic Report
Novo Nordisk tests low-dose Wegovy pill in new study
Novo Nordisk has initiated a low-dose clinical trial for the Wegovy obesity treatment pill, aiming to diversify treatment options.
View Source Article ↗
AI CATALYST SCORE65 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
NVO Analysis History (Last 30 Days)